4//SEC Filing
Societe des Produits Nestle S.A. 4
Accession 0000899243-20-028359
CIK 0001631650other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 7:18 PM ET
Size
9.1 KB
Accession
0000899243-20-028359
Insider Transaction Report
Form 4
Societe des Produits Nestle S.A.
10% Owner
Transactions
- Purchase
Common Stock
2020-10-13$34.50/sh+43,435,583$1,498,527,614→ 43,435,583 total(indirect: See footnote) - Purchase
Common Stock
2020-10-13$34.50/sh+10,681,704$368,518,788→ 23,408,817 total(indirect: See footnote)
Holdings
- 12,727,113
Common Stock
- 525,634
Series A Preferred Stock
Footnotes (3)
- [F1]All of the shares were cancelled on October 13, 2020 pursuant to the terms of that certain Agreement and Plan of Merger, dated as of August 29, 2020 (the "Merger Agreement"), by and among Societe des Produits Nestle S.A. ("SPN"), SPN MergerSub, Inc., a wholly owned subsidiary of SPN ("Merger Sub"), and Aimmune Therapeutics, Inc. ("Aimmune"). Following effectiveness of the merger provided for in the Merger Agreement, SPN owns 100 shares of the common stock of Aimmune, which became a wholly owned subsidiary of SPN as a result of such merger, which represents all of the outstanding shares of common stock of Aimmune.
- [F2]Shares acquired by Merger Sub, upon acceptance of all shares validly tendered and not validly withdrawn pursuant to the tender offer by Merger Sub and SPN, pursuant to the Merger Agreement, for any and all outstanding shares of Aimmune common stock pursuant to that certain Offer to Purchase dated September 14, 2020.
- [F3]Shares acquired pursuant to the merger provided for in the Merger Agreement.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
IncorporatedSwitzerland
Related Parties
1- filerCIK 0001803539
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 7:18 PM ET
- Size
- 9.1 KB